| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.26 | 3e-06 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.28 | 5e-06 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.23 | 8e-05 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.19 | 0.0009 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.19 | 0.001 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.004 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |